Amphetamine Addiction Clinical Trial
Official title:
Randomized Clinical Trial of Robot-Assisted Intelligent Rehabilitation Treatment in Comparison With Standard Treatment for Methamphetamine Use Disorders and Alcohol Use Disorders
The purpose of this research is to evaluate the efficacy and safety of Robot-assisted rehabilitation intelligent system as a virtual stand-alone treatment, delivered with minimal clinical monitoring compared with treatment as usual in methamphetamine (MA) use disorders.
Based on artificial intelligence technology, face recognition technology, virtual reality technology to develop an available Robot-assisted rehabilitation intelligent system. Then, using this intelligent system as a new way of Psychotherapy to provide treatment for methamphetamine patients, and compare it with traditional treatment to verify the efficacy and safety of Robot-assisted rehabilitation intelligent system in Chinese methamphetamine patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
Not yet recruiting |
NCT02836756 -
Cannabidiol as a New Intervention for Amphetamine Dependence
|
Phase 2 | |
Completed |
NCT03318081 -
The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction
|
N/A | |
Completed |
NCT03221283 -
The Application of Music Therapy in Female Amphetamine Use Disorder
|
N/A | |
Withdrawn |
NCT02952196 -
Cannabioids as a New Intervention for Amphetamine Dependence
|
Phase 2 | |
Completed |
NCT02285556 -
The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus
|
N/A | |
Completed |
NCT02713815 -
Novel Intervention for Amphetamine-type Stimulants Addiction
|
N/A | |
Completed |
NCT00713479 -
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
|
Phase 1 | |
Completed |
NCT04993300 -
Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction
|
N/A | |
Completed |
NCT02950376 -
The Novel Addiction Assessment Study in Synthetic Drugs Addiction
|
||
Recruiting |
NCT04687566 -
Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction
|
Phase 2/Phase 3 |